Funding for this research was provided by:
Received: 2 February 2022
Accepted: 28 August 2022
First Online: 7 September 2022
: The collection and archiving of biological samples and clinical data in strictly pseudonymous form in a local biobank and their use in biomarker research were approved by the ethics committee of the University Goettingen (9/2/16). Written informed consent was obtained prior to the inclusion in the biobank from all participants or their legal representatives. All procedures involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Not applicable.
: JW has been an honorary speaker for Actelion, Amgen, Beeijing Yibai Science and Technology Ltd., Janssen Cilag, Med Update GmbH, Pfizer, Roche Pharma, and has been a member of the advisory boards of Abbott, Biogen, Boehringer Ingelheim, Lilly, MSD Sharp & Dohme, and Roche Pharma and receives fees as a consultant for Immungenetics and Roboscreen. JW holds the following patents: PCT/EP 2011 001724 and PCT/EP 2015 052945. SP is a full-time employee of Roche Diagnostics GmbH and holds shares of the company. EM and AJ are full-time employees of Roche Diagnostics GmbH. IL is shareholder and CEO of Roboscreen GmbH, and he and DO are full-time employees of Roboscreen GmbH. JS and ChB are employees of Microdiscovery GmbH, Berlin, Germany. HWK, JV, AJB, HE, BB, CR, CB, and NH declare no competing interests.